SEC Form D · filed February 8, 2023
Spine BioPharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Marc R. Viscogliosi · New York, NYExec · DirectorThomas R. Bumol, Phd · New York, NYDirectorJohn J. Viscogliosi · New York, NYDirectorFrank R. Cammisa, Md · New York, NYDirectorFran R. Magee · New York, NYExecJames Hutchins · NEW YORK, NYDirectorDavid H. Skordal · New York, NYExec · DirectorRichard Crookes · St. Peter's Port, Y7Exec · DirectorNicholas Burnett · Richland, WADirectorThomas R. Bumol, Phd · New York, NYDirectorFrank R. Cammisa, Md · New York, NYDirectorFran R. Magee · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗